Status:
COMPLETED
Medication Regimen Complexity and Glycemic Control in Patients With Diabetes
Lead Sponsor:
Kasr El Aini Hospital
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Polypharmacy is an alarming health issue that is defined as prescription of multiple medications, of which some are redundant or unnecessary. Due to comorbidities, diabetic patients are often prescrib...
Detailed Description
Hypothesis In addition to the side effects and cost of the unnecessary medications, the investigators hypothesis is that poly-pharmacy will adversely affect patients' compliance with the necessary med...
Eligibility Criteria
Inclusion
- All diabetic patients who are eligible by fulfilling all of the following criteria:
- HGBA1c ≥7 mg/dl.
- 2\) Poly-pharmacy: defined as the use of five or more medications.
- Non- compliance: patients were surveyed with both direct and indirect methods to identify non adherence.
Exclusion
- Exclusion after recruitment Any patient whose diabetic medications regimen changed after recruitment due to hospitalisation, illness, stress or patients preference, will be excluded.
Key Trial Info
Start Date :
June 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2017
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT03324971
Start Date
June 2 2017
End Date
December 7 2017
Last Update
September 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo university hospitals
Cairo, Egypt